Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D07CYB
|
|||
Drug Name |
PMID25468267-Compound-56
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
EPITHERAPEUTICS APS
|
|||
Structure |
Download2D MOL |
|||
Formula |
C22H30N4O4
|
|||
Canonical SMILES |
CCN(CCN(C)C)C(=O)CNCC1=NC=CC(=C1)C(=O)OC2=CC=C(C=C2)OC
|
|||
InChI |
1S/C22H30N4O4/c1-5-26(13-12-25(2)3)21(27)16-23-15-18-14-17(10-11-24-18)22(28)30-20-8-6-19(29-4)7-9-20/h6-11,14,23H,5,12-13,15-16H2,1-4H3
|
|||
InChIKey |
VCJMVGNCXKDPNL-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Lysine-specific demethylase 4C (KDM4C) | Target Info | Inhibitor | [1] |
Target's Patent Info | Lysine-specific demethylase 4C (KDM4C) | Target's Patent Info | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | KDM4 histone demethylase inhibitors for anti-cancer agents: a patent review.Expert Opin Ther Pat. 2015 Feb;25(2):135-44. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.